Quince Therapeutics Inc Net Income per Employee (QNCX), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Quince Therapeutics Inc   (NASDAQ: QNCX)
 

Quince Therapeutics Inc Net Income per Employee

QNCX's Quarterly Results, Trends, Rankings, Statistics
Quince Therapeutics Inc 's Income per employee fell in the second quarter 2026 on a trailing twelve month basis to $ 2,060,342, but the productivity of Quince Therapeutics Inc 's 38 employees remained above the company average.
The Healthcare sector has seen Quince Therapeutics Inc achieved the highest income per employee. While income per employee remained unchanged compared to the previous quarter at no. 105.


What is Income per Employee Ratio?






QNCX Net Income per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 2,060,342 2,060,553 -84,579 -396,263 -397,816
QNCX's Total Ranking # 105 # 105 # 2822 # 2884 # 3017
Seq. Net Income Change - 461.67 % 25632.61 % - -


QNCX Net Income per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 12
Overall Market # 105

Net Income per Employee Statistics
High Average Low
$ 2,060,553 $ -489,076 $ -2,366,974
(Mar 31 2026)   (Dec 31 2021)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Rallybio Corporation  3,253,642.86 $ 45.551  Million 14 
Aurinia Pharmaceuticals Inc   2,454,015.63 $ 314.114  Million 128 
Innoviva Inc   2,246,767.30 $ 357.236  Million 159 
Quince Therapeutics Inc   2,060,342.11 $ 78.293  Million 38 
Fortress Biotech Inc   2,030,307.69 $ 158.364  Million 78 
Pulmatrix Inc   1,998,500.00 $ 3.997  Million
Elutia Inc   1,992,615.38 $ 51.808  Million 26 
Rigel Pharmaceuticals Inc  1,850,051.72 $ 321.909  Million 174 
Exelixis Inc   1,653,085.44 $ 1,896.089  Million 1,147 
Actinium Pharmaceuticals Inc  1,514,120.00 $ 37.853  Million 25 
Q32 Bio Inc   1,407,750.00 $ 33.786  Million 24 
Ironwood Pharmaceuticals inc   1,298,680.00 $ 129.868  Million 100 
Agenus Inc  1,135,037.04 $ 91.938  Million 81 
Tg Therapeutics Inc   1,106,491.23 $ 441.490  Million 399 


Date modified: 2026-08-16T08:52:29+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.